Literature DB >> 23560528

The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke.

M-J Cha1, H S Lee, Y D Kim, H S Nam, J H Heo.   

Abstract

BACKGROUND AND
PURPOSE: CHADS2 and CHA2 DS2 -VASc scores are measurement tools that stratify thromboembolic risk in patients with non-valvular atrial fibrillation, and are predictive of cerebral atherosclerosis, fatal stroke and ischaemic heart disease. Patients with higher CHADS2 and CHA2 DS2 -VASc scores are more likely to have had an akinetic/hypokinetic left ventricular segment or a recent myocardial infarction, all of which are associated with coronary artery disease (CAD). Most of the CHADS2 score components are also risk factors for atherosclerosis. Thus, CHADS2 and CHA2 DS2 -VASc scores may be predictive of CAD.
METHODS: In all, 1733 consecutive patients with acute ischaemic stroke who underwent multi-slice computed tomography coronary angiography were enrolled. The association of CHADS2 and CHA2 DS2 -VASc scores with the presence and severity of CAD was investigated.
RESULTS: Of the 1733 patients, 1220 patients (70.4%) had any degree of CAD and 576 (33.3%) had significant CAD (≥ 50% stenosis in at least one coronary artery). As the CHADS2 and CHA2 DS2 -VASc scores increased, the presence of CAD also increased (P < 0.001). The severity of CAD was correlated with CHADS2 score (Spearman coefficient 0.229, P < 0.001) and CHA2 DS2 -VASc score (Spearman coefficient 0.261, P < 0.001). In multivariate analysis, after adjusting for confounding factors, CHADS2 and CHA2 DS2 -VASc scores ≥2 were independently associated with CAD. The CHA2 DS2 -VASc score was a better predictor of the presence of CAD than the CHADS2 score on area under the curve analysis.
CONCLUSION: CHADS2 and CHA2 DS2 -VASc scores were predictive of the presence and severity of CAD in patients with stroke. When a patient has high CHADS2 or CHA2 DS2 -VASc scores, physicians should consider coronary artery evaluation.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Keywords:  CHA2DS2-VAScscore; CHADS2 score; coronary artery disease; stroke

Mesh:

Year:  2013        PMID: 23560528     DOI: 10.1111/ene.12158

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

Review 1.  Brain-heart interaction after acute ischemic stroke.

Authors:  Denise Battaglini; Chiara Robba; Adriana Lopes da Silva; Cynthia Dos Santos Samary; Pedro Leme Silva; Felipe Dal Pizzol; Paolo Pelosi; Patricia Rieken Macedo Rocco
Journal:  Crit Care       Date:  2020-04-21       Impact factor: 9.097

2.  Coronary Artery Disease in Patients Presenting With Acute Ischemic Stroke or Transient Ischemic Attack and Elevated Troponin Levels.

Authors:  Mathieu Kruska; Anna Kolb; Christian Fastner; Iris Mildenberger; Svetlana Hetjens; Maximilian Kittel; Kathrin Bail; Michael Behnes; Ibrahim Akin; Martin Borggrefe; Kristina Szabo; Stefan Baumann
Journal:  Front Neurol       Date:  2022-01-13       Impact factor: 4.003

3.  Association between CHADS2, CHA2DS2-VASc, ATRIA, and Essen Stroke Risk Scores and Functional Outcomes in Acute Ischemic Stroke Patients Who Received Endovascular Thrombectomy.

Authors:  Hyung Jun Kim; Moo-Seok Park; Joonsang Yoo; Young Dae Kim; Hyungjong Park; Byung Moon Kim; Oh Young Bang; Hyeon Chang Kim; Euna Han; Dong Joon Kim; JoonNyung Heo; Jin Kyo Choi; Kyung-Yul Lee; Hye Sun Lee; Dong Hoon Shin; Hye-Yeon Choi; Sung-Il Sohn; Jeong-Ho Hong; Jong Yun Lee; Jang-Hyun Baek; Gyu Sik Kim; Woo-Keun Seo; Jong-Won Chung; Seo Hyun Kim; Sang Won Han; Joong Hyun Park; Jinkwon Kim; Yo Han Jung; Han-Jin Cho; Seong Hwan Ahn; Sung Ik Lee; Kwon-Duk Seo; Yoonkyung Chang; Hyo Suk Nam; Tae-Jin Song
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

4.  Quantifying the risk of heart disease following acute ischaemic stroke: a meta-analysis of over 50,000 participants.

Authors:  Trishna Gunnoo; Nazeeha Hasan; Muhammad Saleem Khan; Julia Slark; Paul Bentley; Pankaj Sharma
Journal:  BMJ Open       Date:  2016-01-20       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.